Amneal Pharmaceuticals (AMRX) News Today $7.54 -0.43 (-5.40%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$7.50 -0.04 (-0.60%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Amneal Pharmaceuticals (NASDAQ:AMRX) Raised to Strong-Buy at StockNews.comMay 6 at 1:37 AM | americanbankingnews.comAquatic Capital Management LLC Buys New Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Aquatic Capital Management LLC purchased a new position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 57,610 shares of the company's stock,May 5 at 4:43 AM | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Position Trimmed by Wells Fargo & Company MNWells Fargo & Company MN lowered its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 56.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 77,973 shares of the company's stock after selling 99,862 shares durinMay 5 at 3:15 AM | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Announces Earnings ResultsAmneal Pharmaceuticals (NASDAQ:AMRX - Get Free Report) released its quarterly earnings results on Friday. The company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.05. Amneal Pharmaceuticals had a negative net margin of 6.88% and a negative return on equity of 346.26%.May 4 at 8:26 AM | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Issues FY 2025 Earnings GuidanceAmneal Pharmaceuticals (NASDAQ:AMRX) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.650-0.70 for the period, compared to the consensus estimate of 0.680. The company also issued revenue guidance of $3.0 billionillion-$3.1 billionillion, compared to the consensus estimate of $3.0 billionillion.May 4 at 7:16 AM | marketbeat.comVoleon Capital Management LP Acquires New Stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Voleon Capital Management LP bought a new position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 55,962 shares of the company's stock, valued at approximately $443,00May 4 at 5:28 AM | marketbeat.comPDT Partners LLC Buys Shares of 79,169 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)PDT Partners LLC purchased a new position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 79,169 shares of the company's stock, valued at approMay 4 at 5:16 AM | marketbeat.comAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2025 Earnings Call TranscriptMay 3 at 9:26 AM | insidermonkey.com46,512 Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Purchased by Nebula Research & Development LLCNebula Research & Development LLC purchased a new position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 46,512 shares of the companyMay 3 at 4:48 AM | marketbeat.comFirst Trust Advisors LP Has $5.33 Million Stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)First Trust Advisors LP boosted its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 9.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 672,403 shares of the companyMay 3 at 4:02 AM | marketbeat.comAmneal Pharmaceuticals, Inc. (AMRX) Q1 2025 Earnings Call TranscriptMay 2, 2025 | seekingalpha.comAmneal Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 2, 2025 | seekingalpha.comAmneal (NASDAQ:AMRX) Misses Q1 Sales Targets, Stock Drops 11.3%May 2, 2025 | finance.yahoo.comAmneal Reports First Quarter 2025 Financial ResultsMay 2, 2025 | businesswire.comBarclays PLC Purchases 56,110 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Barclays PLC boosted its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 18.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 352,494 shares of the company's stock after buying an additional 56,110 shares during the peMay 2, 2025 | marketbeat.com2AMRX : Examining the Future: Amneal Pharmaceuticals's Earnings OutlookMay 1, 2025 | benzinga.comAmneal (AMRX) To Report Earnings Tomorrow: Here Is What To ExpectMay 1, 2025 | msn.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is Nantahala Capital Management LLC's 10th Largest PositionNantahala Capital Management LLC boosted its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 37.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,665,529 shares ofApril 30, 2025 | marketbeat.com371,996 Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. bought a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 371,996 shares of the company's stock, valued at approximately $2,946,April 30, 2025 | marketbeat.comOxford Asset Management LLP Invests $440,000 in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Oxford Asset Management LLP bought a new position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 55,526 shares of the company'April 29, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Sold by Walleye Capital LLCWalleye Capital LLC lessened its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 70.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 38,979 shares of the company's stock after selling 92,688 shares during tApril 27, 2025 | marketbeat.com2 Reasons to Avoid AMRX and 1 Stock to Buy InsteadApril 24, 2025 | finance.yahoo.comBlackBarn Capital Partners LP Grows Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)BlackBarn Capital Partners LP increased its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 18.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,850,000 shares of the company's stock afteApril 24, 2025 | marketbeat.comMariner LLC Acquires 413,268 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Mariner LLC raised its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 3,749.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 424,291 shares of the company's stock after buying an additional 413,2April 23, 2025 | marketbeat.com165,916 Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Purchased by Jump Financial LLCJump Financial LLC bought a new stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 165,916 shares of the company's stock, valued at approximately $1,314,000. JuApril 22, 2025 | marketbeat.comRenaissance Technologies LLC Lowers Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Renaissance Technologies LLC cut its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 9.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 686,500 shares of the company's stockApril 22, 2025 | marketbeat.comInvesco Ltd. Has $15.11 Million Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Invesco Ltd. decreased its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 17.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,907,246 shares of the company's stock after selling 389,951 sharesApril 22, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Recommendation of "Buy" by BrokeragesAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has been given an average rating of "Buy" by the five research firms that are currently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 1-year price target among analystsApril 21, 2025 | marketbeat.comRussell Investments Group Ltd. Raises Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Russell Investments Group Ltd. increased its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 60.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 265,927 shares oApril 21, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 38.4% in MarchAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 4,430,000 shares, a growth of 38.4% from the March 15th total of 3,200,000 shares. Currently, 3.2% of the company's stock are sold short. Based on an average trading volume of 1,650,000 shares, the short-interest ratio is presently 2.7 days.April 20, 2025 | marketbeat.comEven though Amneal Pharmaceuticals (NASDAQ:AMRX) has lost US$78m market cap in last 7 days, shareholders are still up 125% over 5 yearsApril 17, 2025 | finance.yahoo.comJPMorgan Chase & Co. Sells 82,122 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)JPMorgan Chase & Co. trimmed its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 6.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,214,972 shares of the company'sApril 16, 2025 | marketbeat.comIs Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth?April 15, 2025 | insidermonkey.comMartingale Asset Management L P Has $1.19 Million Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Martingale Asset Management L P increased its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 56.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 149,648 shares of the company's stock afterApril 14, 2025 | marketbeat.comExodusPoint Capital Management LP Makes New Investment in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)ExodusPoint Capital Management LP purchased a new position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 108,267 shares of the company's stock, valued at aApril 13, 2025 | marketbeat.comAmneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness MonthApril 11, 2025 | finance.yahoo.comVanguard Group Inc. Grows Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Vanguard Group Inc. boosted its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 14,841,969 shares of the company's stock after buying an additional 218,025 sharesApril 10, 2025 | marketbeat.comTrexquant Investment LP Has $3.67 Million Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Trexquant Investment LP increased its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 93.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 462,720 shares of the company's stockApril 8, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Sold by Arrowstreet Capital Limited PartnershipArrowstreet Capital Limited Partnership reduced its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 25.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,541,058 shares of thApril 7, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Bought by Sei Investments Co.Sei Investments Co. lifted its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 14.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 339,461 shares of the company's stock aApril 6, 2025 | marketbeat.comAmneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.April 3, 2025 | finance.yahoo.comAmneal gets expanded insurance coverage for its Parkinson’s disease treatmentApril 3, 2025 | msn.comAmneal Pharmaceuticals announces expanded coverage for CrexontApril 3, 2025 | markets.businessinsider.comDiametric Capital LP Makes New $252,000 Investment in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Diametric Capital LP purchased a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 31,782 shares of the company's stock, valued at approximaApril 3, 2025 | marketbeat.comAmneal Pharmaceuticals announces U.S. launch of BoruzuApril 2, 2025 | markets.businessinsider.comAmneal Pharmaceuticals (NASDAQ:AMRX) Trading Up 3.6% - Time to Buy?Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 3.6% - Should You Buy?April 1, 2025 | marketbeat.comAmneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell LymphomaApril 1, 2025 | finance.yahoo.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Purchased by Prudential Financial Inc.Prudential Financial Inc. boosted its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 29.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,183,781 shares of the company's stock after buying an addiMarch 31, 2025 | marketbeat.comRaymond James Financial Inc. Invests $2.95 Million in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Raymond James Financial Inc. acquired a new position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 371,996 shares of the company'sMarch 30, 2025 | marketbeat.comSwiss National Bank Buys 31,900 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Swiss National Bank lifted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 13.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 274,000 shares of the company's stock after acquiring anMarch 28, 2025 | marketbeat.com Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address AMRX Media Mentions By Week AMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼1.080.72▲Average Medical News Sentiment AMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼225▲AMRX Articles Average Week Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ROIV News Today RVMD News Today LNTH News Today BBIO News Today BPMC News Today TLX News Today SRPT News Today LEGN News Today TGTX News Today VRNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMRX Stock Free AMRX Stock Alerts